abstract |
The present invention relates to 8-[(1R) -1- (3,5-difluorophenylamino) ethyl] -N, N-dimethyl-2-morpholino-4-oxo-4H-chromene-6 in the treatment or prevention of cancer. -Use of a carboxamide or a combination comprising a pharmaceutically acceptable salt thereof and a taxane; a pharmaceutical composition comprising compound [I] (or a pharmaceutically acceptable salt thereof) and a taxane; compound [I] or pharmaceutically A kit comprising an acceptable salt and taxane, optionally together with instructions; and compound [I] or a pharmaceutically acceptable salt and taxane thereof, simultaneously and sequentially to a warm-blooded animal such as a human. Or a method of treatment comprising administering separately. [Selection] Figure 1 |